
Sanofi India's standalone net profit declined 32.4% to Rs 61.7 crore in Q4 2025, with sales down 18.5% to Rs 419.8 crore, reflecting weaker earnings and a 5% drop in share price. Conversely, Sanofi Consumer Healthcare India reported a 50.1% net profit increase to Rs 66.5 crore and a 47% rise in sales to Rs 251 crore in the same quarter, driven by product relaunches and export growth, leading to a 14% surge in its shares and a declared Rs 75 per share dividend.
Select a news story to see related coverage from other media outlets.